Health TrialsbyHealthPanel

Efficacy of Platelet-rich Plasma Injection Compare With Corticosteroid in Pes Anserinus Pain Syndrome

ConditionsPes Anserine BursitisSteroid InjectionPRP Injection
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRamathibodi Hospital

About this trial

The goal of this research is to study the efficacy of treatment between PRP injection and corticosteroid injection in patients with pes anserinus bursitis. The research question is whether PRP can reduce pain more effectively than corticosteroids.

The study is divided into two groups: one group receiving PRP injections and the second group receiving corticosteroid injections. Treatment outcomes will be monitored at four time points: baseline, 4 weeks, 12 weeks, and 24 weeks. The outcomes will be measured using the VAS and WOMAC scores.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Over 18 years old

Patients diagnosed with Pes Anserine Pain Syndrome

Patients willing to participate in the research project by signing a consent form

Disqualifiers

Patients with a localized knee infection or a disseminated infection within the past 3 months

Patients with thyroid disorders, rheumatoid arthritis, or other types of knee arthritis

Patients with abnormal blood coagulation or thrombocytopenia

Patients who are pregnant

Trial design

Design model

Parallel

Treatments tested in this trial

  • PRP injection

    Drug

    Receive pes anserinus PRP injection

  • corticosteroid injection

    Drug

    Receive pes anserinus corticosteroid injection

Treatment groups

24 Participants
are divided into 2 treatment groups
Group A: PRP injectionExperimental treatment 1 intervention
Group B: Corticosteroid injectionActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Visual analogue scale (VAS)

Pain relief outcome : Visual analogue scale (VAS) scale 0(minimum pain) to 10(maximum pain)

Time frame
6 months

Secondary outcomes

1

WOMAC score

Functional outcomes : The Western Ontario and McMaster Universities Arthritis Index(WOMAC) version 3.01 Thai version

Time frame
6 months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ramathibodi Hospital

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: